HomeInsightsPE

Eris Lifesciences Ltd PE Ratio

Eris Lifesciences Ltd PE Ratio

stocks purchased

₹ 0.7 Cr

Volume transacted

stocks purchased

5.3 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

ERIS Lifesciences Ltd

NSE: ERIS

PE

50.5

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of ERIS Lifesciences Ltd is 50.5 as of 19 Sep 15:30 PM.
  • The P/E Ratio of ERIS Lifesciences Ltd changed from 30.5 on March 2019 to 29.2 on March 2024 . This represents a CAGR of -0.72% over 6 years. .
  • The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1410 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of ERIS Lifesciences Ltd

No data available

Company Fundamentals for ERIS Lifesciences Ltd

No data available

Image

ERIS Lifesciences Ltd

NSE: ERIS

PRICE

1410.15

13.85 (0.99%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20241410.15
18 Sep 20241396.3
17 Sep 20241391
16 Sep 20241388.15
13 Sep 20241394.6
12 Sep 20241435.35
11 Sep 20241452.55
10 Sep 20241466.95
09 Sep 20241464
06 Sep 20241447.8

SWOT Analysis Of ERIS Lifesciences Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for ERIS Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of ERIS Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of ERIS Lifesciences Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of ERIS Lifesciences Ltd

No data available

* All values are in %

About ERIS Lifesciences Ltd

  • Eris Lifesciences Limited was incorporated on January 25, 2007.
  • Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
  • Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
  • The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
  • It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors.

ERIS Lifesciences Ltd News Hub

News

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will...

Read more

05 Aug 202418:42

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 2 August...

Read more

31 Jul 202412:40

News

Eris Lifesciences allots 22,492 equity shares under ESOP

Eris Lifesciences has allotted 22,492 equity shares under ESOP on 20 June 2024. The paid u...

Read more

24 Jun 202412:26

News

Board of ERIS Lifesciences approves composite scheme of arrangement

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite s...

Read more

21 May 202418:42

News

Board of ERIS Lifesciences approves NCD issuance up to Rs 1250 cr

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved issuance of...

Read more

21 May 202418:40

News

ERIS Lifesciences to table results

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 21 May 2...

Read more

15 May 202415:28

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of ERIS Lifesciences Ltd

What is the current PE Ratio of ERIS Lifesciences Ltd?

The Current PE Ratio of ERIS Lifesciences Ltd is 50.45 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of ERIS Lifesciences Ltd last year?

The PE Ratio of ERIS Lifesciences Ltd was 20.36 last year, now the PE ratio is 50.45, showing a year-on-year growth of 147.8%.

What does the PE Ratio of ERIS Lifesciences Ltd indicate about its stock?

The PE Ratio of ERIS Lifesciences Ltd is 50.45. This ratio indicates that investors are willing to pay 50.45 times the earnings per share for each share of ERIS Lifesciences Ltd.

What is the PE Ratio Growth of ERIS Lifesciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of ERIS Lifesciences Ltd grew by 147.8% whereas, the EPS ratio grew by 17.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*